Tori Whitacre Martonicz is the senior editor of Infection Control Today. She has been a writer and editor for over 30 years and has an MA and BA in English Composition/Literature from the University of Akron in Akron, OH. She lives in Ohio with her husband; son; 2 tiny dogs, Selena Brigid Sophia and Doctor Danger Dog; and a big black cat, Freya. She loves reading, writing, gardening, and spending time with her loved ones. Contact her through her email: tmartonicz@mjhlifesciences.com.
The healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.
Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.
A senior microbiologist gives audiences of sister brands, Infection Control Today and Contagion, an insight into leishmaniasis, a potentially fatal disease.
Salem Hospital faces a class action lawsuit over potential hepatitis and HIV exposure to hundreds of patients. The lawsuit alleges negligence and emotional distress, with the hospital claiming a minimal infection risk.
Published: July 7th 2024 | Updated:
